These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Role of Biomarkers for the Prevention, Assessment, and Management of Heart Failure: A Scientific Statement From the American Heart Association. Chow SL; Maisel AS; Anand I; Bozkurt B; de Boer RA; Felker GM; Fonarow GC; Greenberg B; Januzzi JL; Kiernan MS; Liu PP; Wang TJ; Yancy CW; Zile MR; Circulation; 2017 May; 135(22):e1054-e1091. PubMed ID: 28446515 [TBL] [Abstract][Full Text] [Related]
9. Beyond Natriuretic Peptides: Unveiling the Power of Emerging Biomarkers in Heart Failure. Licordari R; Correale M; Bonanno S; Beltrami M; Ciccarelli M; Micari A; Palazzuoli A; Dattilo G Biomolecules; 2024 Mar; 14(3):. PubMed ID: 38540729 [TBL] [Abstract][Full Text] [Related]
11. Effectiveness and cost-effectiveness of serum B-type natriuretic peptide testing and monitoring in patients with heart failure in primary and secondary care: an evidence synthesis, cohort study and cost-effectiveness model. Pufulete M; Maishman R; Dabner L; Mohiuddin S; Hollingworth W; Rogers CA; Higgins J; Dayer M; Macleod J; Purdy S; McDonagh T; Nightingale A; Williams R; Reeves BC Health Technol Assess; 2017 Aug; 21(40):1-150. PubMed ID: 28774374 [TBL] [Abstract][Full Text] [Related]
12. The emerging role of Galectin-3 and ST2 in heart failure: practical considerations and pitfalls using novel biomarkers. Karayannis G; Triposkiadis F; Skoularigis J; Georgoulias P; Butler J; Giamouzis G Curr Heart Fail Rep; 2013 Dec; 10(4):441-9. PubMed ID: 24142671 [TBL] [Abstract][Full Text] [Related]
13. Established and Emerging Roles of Biomarkers in Heart Failure. Ibrahim NE; Januzzi JL Circ Res; 2018 Aug; 123(5):614-629. PubMed ID: 30355136 [TBL] [Abstract][Full Text] [Related]
14. Biomarkers in heart failure: the past, current and future. Sarhene M; Wang Y; Wei J; Huang Y; Li M; Li L; Acheampong E; Zhengcan Z; Xiaoyan Q; Yunsheng X; Jingyuan M; Xiumei G; Guanwei F Heart Fail Rev; 2019 Nov; 24(6):867-903. PubMed ID: 31183637 [TBL] [Abstract][Full Text] [Related]
15. Rationale and design of the GUIDE-IT study: Guiding Evidence Based Therapy Using Biomarker Intensified Treatment in Heart Failure. Felker GM; Ahmad T; Anstrom KJ; Adams KF; Cooper LS; Ezekowitz JA; Fiuzat M; Houston-Miller N; Januzzi JL; Leifer ES; Mark DB; Desvigne-Nickens P; Paynter G; Piña IL; Whellan DJ; O'Connor CM JACC Heart Fail; 2014 Oct; 2(5):457-65. PubMed ID: 25194287 [TBL] [Abstract][Full Text] [Related]
16. Biomarkers for the diagnosis and management of heart failure. Castiglione V; Aimo A; Vergaro G; Saccaro L; Passino C; Emdin M Heart Fail Rev; 2022 Mar; 27(2):625-643. PubMed ID: 33852110 [TBL] [Abstract][Full Text] [Related]
17. A Novel Paradigm Based on ST2 and Its Contribution towards a Multimarker Approach in the Diagnosis and Prognosis of Heart Failure: A Prospective Study during the Pandemic Storm. Miftode RS; Constantinescu D; Cianga CM; Petris AO; Timpau AS; Crisan A; Costache II; Mitu O; Anton-Paduraru DT; Miftode IL; Pavel-Tanasa M; Cianga P; Serban IL Life (Basel); 2021 Oct; 11(10):. PubMed ID: 34685450 [TBL] [Abstract][Full Text] [Related]
18. Clinical relevance of biomarkers in heart failure and cardiorenal syndrome: the role of natriuretic peptides and troponin. Palazzuoli A; Masson S; Ronco C; Maisel A Heart Fail Rev; 2014 Mar; 19(2):267-84. PubMed ID: 23563622 [TBL] [Abstract][Full Text] [Related]
19. Biomarkers and heart disease. Sun RR; Lu L; Liu M; Cao Y; Li XC; Liu H; Wang J; Zhang PY Eur Rev Med Pharmacol Sci; 2014 Oct; 18(19):2927-35. PubMed ID: 25339488 [TBL] [Abstract][Full Text] [Related]
20. Clinical and Prognostic Significance of sST2 in Heart Failure: JACC Review Topic of the Week. Aimo A; Januzzi JL; Bayes-Genis A; Vergaro G; Sciarrone P; Passino C; Emdin M J Am Coll Cardiol; 2019 Oct; 74(17):2193-2203. PubMed ID: 31648713 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]